Funding for this research was provided by:
National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology (2012ZX09303006-001)
National Major Science and Technology Projects of China (2011ZX09307-001-08)
Chinese Society of Endocrinology, the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044)
National High Technology Research and Development Program of China (2011AA020107)
Received: 29 September 2019
Accepted: 16 June 2020
First Online: 27 June 2020
Ethics approval and consent to participate
: All participants were given written informed consent for authorizing researchers to use their information. The study protocol was approved by the Committee on Human Research at Rui-Jin Hospital affiliated with the School of Medicine, Shanghai Jiao Tong University.
: Not applicable.
: The authors declare that they have no conflict of interests.